COMP <GO>
ALB vs LIN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Albemarle Corporation (NYSE) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: ALB 3
— LIN 9
■ METRIC PARITY
LAST: $91.00 (-2.43%) • MKT CAP: $11.01B
options-implied-move
6.90%
LAST: $514.24 (+2.20%) • MKT CAP: $231.94B
options-implied-move
6.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALB VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALB | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.00% | 41.00% | -28.00 | LIN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.60% | 13.10% | -15.70 | LIN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.29% | 2.19% | +4.10 | ALB | /fcf-yield <GO> |
| Operating Margin | -7.10% | 26.30% | -33.40 | LIN | /operating-margins <GO> |
| Net Profit Margin | -9.90% | 20.30% | -30.20 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) | -4.40% | 3.00% | -7.40 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.73% | 1.21% | +0.52 | ALB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.64 | 3.93 | -2.29 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | LIN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.90% | 6.90% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.0 | 69.3 | -37.24 | LIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.01 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 31.2x | -11.20 | ALB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.01B | $231.94B | -$220.94B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALB REV | LIN REV | ALB GROSS % | LIN GROSS % | ALB FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.14B | $33.99B | 13.0% | 44.0% | $692.5M | $5.09B |
| FY 2024 | $5.38B | $33.01B | 1.2% | 44.0% | -$992.7M | $4.93B |
| FY 2023 | $9.62B | $32.85B | 44.0% | 44.0% | $893.8M | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALB // BETA 1.01
LIN // BETA 1.01